Research ArticleRheumatoid Arthritis
Open Access
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials
Louis Bessette, Eduardo Mysler, Cassandra D. Kinch, Kenneth Kwok, Tatjana Lukic, Phu Vinh On and Ronald F. van Vollenhoven
The Journal of Rheumatology June 2022, 49 (6) 566-576; DOI: https://doi.org/10.3899/jrheum.210707
Louis Bessette
1L. Bessette, MD, MSc, Department of Medicine, Laval University, Quebec, Quebec, Canada;
Eduardo Mysler
2E. Mysler, MD, Organización Médica de Investigación, Buenos Aires, Argentina;
Cassandra D. Kinch
3C.D. Kinch, PhD, P.V. On, MSc, Pfizer Canada ULC, Kirkland, Quebec, Canada;
Kenneth Kwok
4K. Kwok, MS, T. Lukic, MD, MSc, Pfizer Inc, New York, New York, USA;
Tatjana Lukic
4K. Kwok, MS, T. Lukic, MD, MSc, Pfizer Inc, New York, New York, USA;
Phu Vinh On
3C.D. Kinch, PhD, P.V. On, MSc, Pfizer Canada ULC, Kirkland, Quebec, Canada;
Ronald F. van Vollenhoven
5R.F. van Vollenhoven, MD, PhD, Amsterdam Rheumatology and Immunology Center, and Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
REFERENCES
- 1.↵
- Ward MM,
- Guthrie LC,
- Alba MI.
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- Smolen JS,
- Aletaha D.
- 8.↵
- Smolen JS,
- Breedveld FC,
- Burmester GR, et al.
- 9.↵
- Kremer JM,
- Bloom BJ,
- Breedveld FC, et al.
- 10.↵
- 11.↵
- Fleischmann R,
- Cutolo M,
- Genovese MC, et al.
- 12.↵
- Kremer JM,
- Cohen S,
- Wilkinson BE, et al.
- 13.↵
- 14.↵
- 15.
- 16.↵
- 17.↵
- 18.
- 19.↵
- 20.↵
- van der Heijde D,
- Strand V,
- Tanaka Y, et al.
- 21.↵
- Fleischmann R,
- Mysler E,
- Hall S, et al.
- 22.↵
- Wollenhaupt J,
- Silverfield J,
- Lee EB, et al.
- 23.↵
- 24.↵
- 25.↵
- Cohen SB,
- Tanaka Y,
- Mariette X, et al.
- 26.↵
- 27.↵
- 28.↵
- Rigby WF,
- Burmester GR,
- FitzGerald O, et al.
- 29.↵
- Canhão H,
- Rodrigues AM,
- Gregório MJ, et al.
- 30.↵
- Gossec L,
- Dougados M,
- Dixon W.
- 31.↵
- 32.↵
- Challa DN,
- Kvrgic Z,
- Cheville AL, et al.
- 33.↵
- Smolen JS,
- Strand V,
- Koenig AS,
- Szumski A,
- Kotak S,
- Jones TV.
- 34.↵
- 35.↵
- 36.↵
- 37.↵
- Fleischmann R,
- Strand V,
- Wilkinson B,
- Kwok K,
- Bananis E.
- 38.↵
- Fautrel B,
- Kirkham B,
- Pope JE, et al.
- 39.↵
- Fautrel B,
- Zhu B,
- Taylor PC, et al.
- 40.↵
- Strand V,
- Mysler E,
- Moots RJ, et al.
- 41.↵
- Strand V,
- Kaine J,
- Alten R, et al.
- 42.↵
- Masri KR,
- Shaver TS,
- Shahouri SH, et al.
In this issue
The Journal of Rheumatology
Vol. 49, Issue 6
1 Jun 2022
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials
Louis Bessette, Eduardo Mysler, Cassandra D. Kinch, Kenneth Kwok, Tatjana Lukic, Phu Vinh On, Ronald F. van Vollenhoven
The Journal of Rheumatology Jun 2022, 49 (6) 566-576; DOI: 10.3899/jrheum.210707
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials
Louis Bessette, Eduardo Mysler, Cassandra D. Kinch, Kenneth Kwok, Tatjana Lukic, Phu Vinh On, Ronald F. van Vollenhoven
The Journal of Rheumatology Jun 2022, 49 (6) 566-576; DOI: 10.3899/jrheum.210707